You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • OP0227 SECUKINUMAB VERSUS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 52-WEEKS (EXCEED): A RANDOMISED, DOUBLE-BLIND, PHASE-3B STUDY

Article metrics

Article menu

Download PDFPDF

Scientific Abstracts
Oral Presentations
Update on new treatment options for psoriatic arthritis
OP0227 SECUKINUMAB VERSUS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 52-WEEKS (EXCEED): A RANDOMISED, DOUBLE-BLIND, PHASE-3B STUDY
Free

 

Online download statistics by month:

Online download statistics by month: June 2020 to May 2023

AbstractFullPdf
Jun 2020176022
Jul 202065014
Aug 202081013
Sep 2020120016
Oct 202090013
Nov 2020305023
Dec 202094020
Jan 2021158020
Feb 2021154020
Mar 2021131016
Apr 202199015
May 202127010
Jun 2021008
Jul 20211013
Aug 2021109
Sep 20210011
Oct 202173024
Nov 202161023
Dec 20212104
Jan 20224204
Feb 20225604
Mar 20225809
Apr 20224504
May 202294015
Jun 202296032
Jul 202279031
Aug 202260013
Sep 202276026
Oct 202282055
Nov 202290017
Dec 202246014
Jan 202340012
Feb 202358019
Mar 202372060
Apr 202334018
May 202362017
Total27470644